GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, APP, CBR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, ESR1, FABP3, FABP4, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MET, MIF, PDE3A, PPARA, TRPV1 |
13.958 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APP, AXL, BCL2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, HMGCR, HSD11B2, HSD17B2, IGF1R, MMP2, MMP9, NR3C1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, RORC, SRC, TRPV1, TYR |
13.3778 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, IGF1R, KDR, MMP2, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, RORC, SRC, TRPV1, TYR |
12.3024 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CDK6, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, ESR1, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, KDR, MET, MIF, OPRD1, OPRK1, OPRM1, PDE3A, PPARA, SRC, TNKS, TNKS2, TRPV1, XDH |
11.3681 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HTR2A, IGF1R, KDR, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, RORC, SRC, TRPV1, TYR |
11.1595 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
11.1391 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, FLT3, HSD11B2, NR3C1, OPRK1, OPRM1, PDE3A, RORC, SRC, TRPV1, TYR |
10.8361 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FUT7, GBA2, HMGCR, MIF, PDE10A, PDE3A, PDE3B, PIM1, PPARA, TYR, XDH |
10.2734 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
9.4529 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
9.4388 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, ESR1, ESRRA, FABP3, FLT3, HSD11B2, IGF1R, MMP2, NR3C1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TRPV1 |
9.24276 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, HSD17B2, NR3C1, OPRK1, OPRM1, RORC, SRC, TYR |
9.12534 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRB, F3, FABP4, HMGCR, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, MET, MMP1, MMP12, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PPARA, RORC, SRC, TNKS2, TRPV1, TYR |
9.00309 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, ALOX12, APP, BCL2, CDC25B, CDK6, CSNK2A1, CYP1B1, DRD2, ESR1, ESRRA, F3, FABP3, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, OPRM1, PIM1, SRC, XDH |
8.5798 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
8.52322 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, FLT3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
8.49872 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CDK6, DRD1, DRD2, HMGCR, HTR2A, KDR, MIF, OPRK1, SRC, TNKS, TNKS2, TRPV1 |
8.2926 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, RORC, SRC, TRPV1 |
8.2926 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, GBA2, HMGCR, HTR1A, TYR |
8.17931 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, AXL, BCL2, CA9, CDK6, CYP1A1, CYP1B1, DRD1, DRD2, FABP3, HMGCR, HSD11B2, HTR2A, KDR, NR3C1, OPRK1, OPRM1, PDE3A, SRC, TRPV1 |
8.16451 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
8.11749 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, RORC, SRC, TRPV1 |
8.10791 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, ESR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, OPRK1 |
7.93269 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX12, ALOX15, ALOX5, CBR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD2, FABP3, FABP4, FUT7, GBA2, HMGCR, MET, MIF, PDE3A, PPARA |
7.8632 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2D6, TYR |
7.72081 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, BCL2, CA2, CA9, CSNK2A1, CYP1A2, ESR1, ESRRA, FABP3, FLT3, HSD11B2, NR3C1, OPRK1, PDE3B, PPARA, SRC, TRPV1 |
7.20477 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
7.1389 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD17B2, HTR2A, KDR, MET, MIF, MMP2, MMP9, PDE3A, PDE3B, PIM1, PPARA, RORC, SIGMAR1, SRC, TNKS2, TYR |
7.07499 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
6.97297 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
6.9511 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, ALOX12, BCL2, CDC25B, CDK6, CSNK2A1, DRD2, ESR1, F3, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, PIM1 |
6.92713 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
6.8436 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
6.80593 |
[BP] GO:0032845 |
None
|
ADORA1, BCL2, DRD2, HMGCR, HTR2A, MIF, SRC, TNKS, TNKS2, TRPV1 |
6.80593 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
6.77995 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP2, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
6.77371 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
6.75966 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.71456 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, APP, AXL, BCL2, CA2, CA7, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, F3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, TRPV1 |
6.68956 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, F3, FLT3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
6.62559 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B2, HSD17B2, HTR1A, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, PTPN1, RORC, SRC, TRPV1, TYR |
6.53728 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
6.52402 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, FABP4, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
6.44511 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, F3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, XDH |
6.44511 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
6.40665 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
6.39678 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, DRD2, F3, FLT3, HMGCR, HTR2A, KDR, MET, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
6.35977 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APP, CYP1A1, CYP1B1, DRD1, ESR1, FLT3, NR3C1, OPRM1, PDE3A, RORC, SRC, TRPV1 |
6.31084 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, F3, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
6.29085 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
6.28351 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
6.28351 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, HMGCR, HSD11B2, HTR2A, MMP2, OPRD1, OPRK1, OPRM1, PPARA, SRC, TRPV1, TYR |
6.19633 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
6.19504 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
6.16644 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CA2, CA9, CDK6, CYP1A1, CYP1A2, CYP1B1, DRD1, ESR1, FABP4, FLT3, IGF1R, KDR, MIF, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, RORC, SRC, TRPV1 |
6.16644 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PPARA, PTPN1, SIGMAR1, SRC, TRPV1, XDH |
6.05329 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, AKR1B1, APP, AXL, BCL2, CA1, CA2, CDK6, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TRPV1 |
5.99689 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, TRPV1, XDH |
5.99689 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, FABP4, KDR, MMP9, SRC |
5.92818 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.86655 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, XDH |
5.81136 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA7, CA9 |
5.76543 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APP, AXL, CDK6, CYP1B1, DRD1, ESR1, IGF1R, MMP2, MMP9, NR3C1, OPRK1, PDE3A, PDE3B, RORC, SRC, TRPV1 |
5.75655 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, AXL, BCL2, CYP1A1, CYP1B1, DRD1, DRD2, HMGCR, KDR, OPRD1, OPRK1, SRC |
5.71541 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APP, DRD1, DRD2, FABP3, FLT3, HSD11B2, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TRPV1, TYR |
5.71283 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, ESRRB, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
5.59428 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESRRA, F3, FABP4, FLT3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PTPN1, SRC, TNKS, TNKS2, XDH |
5.58292 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, DRD1, DRD2, HTR2A, KDR, SRC, TRPV1 |
5.556 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, OPRK1, SRC |
5.52765 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, MIF |
5.52583 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.52583 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
5.45722 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
5.45722 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, ESR1, F3, FLT3, HMGCR, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SIGMAR1, SRC, TRPV1, XDH |
5.45722 |
[BP] GO:0038003 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.41362 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, ESR1, HTR7, OPRK1, OPRM1, PPARA, RORC, SRC |
5.37947 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, F3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP2, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PPARA, PTPN1, SRC, TNKS, TNKS2, XDH |
5.29983 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APP, DRD1, DRD2, FABP3, FLT3, HSD11B2, IGF1R, MMP2, OPRK1, OPRM1, PDE3A, PDE3B, PPARA, SRC, TRPV1, TYR |
5.29983 |
[BP] GO:0007193 |
None
|
ADORA1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
5.29983 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
5.28897 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, AKR1B1, ALOX12, DRD1, DRD2, HTR2A, MET, TRPV1 |
5.276 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, GBA2, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, SRC, XDH |
5.2376 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, MIF, PPARA |
5.2376 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
5.20616 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PPARA, PTPN1, SRC |
5.17536 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PIM1, PPARA, RORC, SRC |
5.15093 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, PDE3A |
5.11206 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX12, ALOX15, CSNK2A1, CYP19A1, CYP1A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, MIF |
5.10794 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.09655 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
5.06561 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MET, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
5.01028 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC |
5.01028 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, ESRRB, FABP3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, XDH |
5.01028 |
[BP] GO:0007200 |
None
|
DRD1, DRD2, ESR1, HTR2A, OPRD1, OPRK1, OPRM1 |
4.9667 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.94396 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ALOX12, APP, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PIM1, SRC, TNKS2, TRPV1, XDH |
4.89874 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, ALOX12, APP, BCL2, CDK6, CYP19A1, CYP1B1, DRD1, DRD2, F3, IGF1R, KDR, MET, MIF, MMP9, SRC |
4.85377 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.85046 |
[BP] GO:0030534 |
None
|
APP, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, PPARA |
4.78357 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HMGCR, HTR2A, KDR, MIF, OPRM1, SRC |
4.77105 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, XDH |
4.74717 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD1, DRD2, ESR1, ESR2, HMGCR, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, XDH |
4.68704 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD1, DRD2, ESR1, ESR2, HMGCR, HTR2A, IGF1R, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE3B, PTPN1, SRC, XDH |
4.66847 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, DRD1, DRD2, HTR1A, HTR2A, MIF, MMP9, OPRD1, OPRK1, OPRM1 |
4.66293 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD2, ESR1, FABP4, HMGCR, IGF1R, MET, MMP9, OPRM1, PIM1, PPARA, PTPN1, SRC, TNKS |
4.64526 |
[BP] GO:0001659 |
None
|
ADORA1, DRD1, DRD2, HTR2A, TRPV1 |
4.6202 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DRD2, HMGCR, HTR2A, KDR, MIF, OPRM1, PTPN1, SRC |
4.61406 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DRD2, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, OPRK1, OPRM1, PTPN1, SRC, XDH |
4.60353 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX12, ALOX15, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6 |
4.60116 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CYP19A1, DRD1, DRD2, HMGCR, HTR1A, HTR2A, MIF, MMP12, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, TRPV1 |
4.59024 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, AXL, CDK6, CYP1B1, DRD1, KDR, NR3C1, OPRM1, SRC, TRPV1 |
4.51088 |
[BP] GO:0003018 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7, PDE3A, SRC |
4.48803 |
[BP] GO:0007188 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
4.46966 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GBA2, HMGCR, HTR1A, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
4.41994 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, PDE3A |
4.41994 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.41994 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, DRD2, FLT3, HMGCR, IGF1R, KDR, MET, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SRC, TNKS, XDH |
4.41994 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, ALOX12, AURKB, AXL, BCL2, CSNK2A1, HMGCR, IGF1R, KDR, MIF, MMP9, PDE3A, PIM1, PTPN1, SRC |
4.41994 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX12, ALOX15, BCL2, CDK6, CYP19A1, DRD1, DRD2, ESR1, ESR2, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, PDE3B, PPARA, PTPN1, SRC, XDH |
4.37597 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESRRA, ESRRB, FLT3, GBA2, HSD11B1, HSD17B2, KDR, MMP9, PIM1, PPARA, RORC, SIGMAR1, SRC, TYR |
4.36986 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC, SRC |
4.26702 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, ESR1, ESR2, F3, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, OPRK1, OPRM1, PDE10A, PDE3B, PTPN1, SRC, TNKS, TNKS2, XDH |
4.23341 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APP, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, ESR1, ESR2, ESRRA, FABP4, HMGCR, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRM1, PDE3B, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
4.19585 |
[BP] GO:0032787 |
None
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, MIF, PPARA |
4.17717 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, DRD1, DRD2, ESR1, F3, FABP4, HMGCR, KDR, MET, MIF, MMP12, OPRM1, PPARA |
4.16787 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, HMGCR, HTR2A, KDR, MET, MIF, MMP12, MMP9, OPRM1, PDE3A, PIM1, SRC, TRPV1 |
4.16787 |
[BP] GO:0097756 |
None
|
ADORA1, HMGCR, HTR1A, HTR2A, HTR7 |
4.16536 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, DRD2, OPRM1, PPARA |
4.06321 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, HTR1A, TYR |
4.00192 |
[BP] GO:0007187 |
None
|
ADORA1, DRD1, DRD2, HTR1A, HTR7, OPRD1, OPRK1, OPRM1 |
3.99597 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, ESR1, ESRRA, ESRRB, FLT3, HSD11B1, HSD17B2, KDR, PPARA, SRC, TYR |
3.92085 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, TRPV1 |
3.91783 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, ALOX12, APP, CDK6, CYP19A1, DRD2, ESR1, F3, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP2, OPRK1, PPARA, PTPN1, SRC, XDH |
3.88494 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, OPRD1, PPARA, SRC |
3.88271 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, ESR1, HMGCR, IGF1R, MET, MIF, MMP9, PDE3B, PTPN1, SRC, XDH |
3.86857 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, HTR2A, OPRK1 |
3.83503 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD2, ESR1, F3, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.82965 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.82965 |
[BP] GO:2001300 |
lipoxin metabolic process
|
ALOX12, ALOX15, ALOX5 |
3.80114 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.80114 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, OPRD1, PPARA, SRC |
3.79625 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, AOX1, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2 |
3.79331 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, DRD1, ESR1, ESRRB, HSD11B2, HSD17B2, MMP2, MMP9, OPRK1, OPRM1, PDE3A, SRC |
3.77033 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APP, FABP3, HSD11B2, IGF1R, OPRK1, PDE3B, PPARA, SRC, TRPV1 |
3.77033 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4, GBA2 |
3.7676 |
[BP] GO:0006939 |
None
|
DRD1, DRD2, HTR2A, HTR7, TRPV1 |
3.7676 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, AKR1B1, ALOX12, APP, AXL, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, FLT3, HTR2A, MET, SRC, TRPV1 |
3.76201 |
[BP] GO:0007610 |
None
|
APP, BCL2, DRD1, DRD2, HMGCR, HTR1A, HTR2A, OPRD1, OPRK1, OPRM1, PPARA, TRPV1 |
3.7087 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, XDH |
3.70818 |
[BP] GO:0072523 |
None
|
AOX1, PDE10A, PDE3A, PDE3B, XDH |
3.68814 |
[BP] GO:0003013 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7, PDE3A, SRC |
3.68814 |
[BP] GO:0050793 |
regulation of developmental process
|
ALOX12, APP, AXL, BCL2, CA2, CDK6, CYP1B1, DRD2, ESR1, ESRRA, ESRRB, F3, HMGCR, HTR2A, KDR, MIF, OPRM1, PDE3A, PDE3B, PIM1, PPARA, RORC, SRC, TNKS2, TRPV1, XDH |
3.66152 |
[BP] GO:0003008 |
None
|
ADORA1, AKR1B1, APP, BCL2, CYP1B1, DRD1, DRD2, HMGCR, HSD11B2, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE3A, SRC, TRPV1, TYR |
3.65878 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CYP1A1, FABP3, FLT3, HMGCR, HTR2A, PDE3B, PPARA, RORC, SRC |
3.65 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD2, ESR1, F3, FLT3, HMGCR, HTR2A, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.6428 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3B, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.64279 |
[BP] GO:0009820 |
alkaloid metabolic process
|
CYP1A2, CYP2D6, CYP3A4 |
3.60913 |
[BP] GO:0007631 |
None
|
APP, DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
3.58476 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.56365 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, HSD11B2, MMP2, OPRD1, PPARA, SRC |
3.54249 |
[BP] GO:0007186 |
G-protein coupled receptor signaling pathway
|
ADORA1, ADORA3, APP, CA2, DRD1, DRD2, ESR1, HTR1A, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, SIGMAR1, SRC |
3.49784 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, F3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MET, MIF, MMP9, OPRD1, OPRM1, PIM1, PPARA, PTPN1, SRC, TNKS, TRPV1, XDH |
3.49281 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APP, DRD1, ESR1, FLT3, IGF1R, MMP2, NR3C1, OPRM1, PDE3A, PDE3B, SRC, TRPV1 |
3.45315 |
[BP] GO:0006367 |
transcription initiation from RNA polymerase II promoter
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
3.38939 |
[BP] GO:0040017 |
positive regulation of locomotion
|
ALOX12, APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, OPRK1, SRC |
3.36512 |
[BP] GO:1901617 |
organic hydroxy compound biosynthetic process
|
AKR1B1, ALOX12, ALOX15, CYP19A1, CYP3A4, HMGCR, TYR |
3.3601 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC, TRPV1 |
3.35636 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
3.3331 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DRD1, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
3.30121 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, ALOX12, APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, FABP4, HTR2A, MET, TRPV1 |
3.29466 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, DRD2, FABP4, MMP9 |
3.2579 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, DRD1, DRD2, HTR2A |
3.22269 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, IGF1R, KDR, MET, MMP12, NR3C1, PPARA, RORC, SRC, TNKS, TNKS2, TRPV1 |
3.17544 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, RORC |
3.17458 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, HMGCR, HTR1A, HTR2A, MIF, MMP12, OPRK1, OPRM1, SRC, TRPV1 |
3.1537 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.1344 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ALPL, APP, AXL, BCL2, CBR1, CDC25B, CDK6, CYP1A1, DRD1, DRD2, ESR1, ESRRB, FABP4, FLT3, FUT7, GBA2, HMGCR, KDR, MET, MIF, MMP2, MMP9, PDE3A, RORC, SRC |
3.12575 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
3.11328 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD17B1, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
3.10477 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, DRD2 |
3.10477 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APP, DRD1, IGF1R, MMP2, OPRM1, PDE3A, PDE3B, SRC, TRPV1 |
3.09055 |
[BP] GO:0031324 |
negative regulation of cellular metabolic process
|
APP, AURKB, BCL2, CSNK2A1, CYP2D6, DRD2, ESR1, ESR2, ESRRA, FABP4, HMGCR, IGF1R, MET, MIF, MMP12, MMP9, NR3C1, OPRM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
3.08134 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD1, DRD2, HTR1A |
3.07399 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CYP1A1, HMGCR, HSD11B2, OPRM1, SRC, TRPV1, TYR |
3.06106 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, DRD1, DRD2 |
3.04868 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, SRC, TNKS |
3.03748 |
[BP] GO:0008306 |
None
|
APP, DRD1, DRD2, HMGCR, OPRK1 |
3.03262 |
[BP] GO:1901575 |
None
|
ACHE, ADORA1, AKR1B10, AOX1, AURKB, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, FUT7, GBA2, PDE10A, PDE3A, PDE3B, XDH |
3.03121 |
[BP] GO:0051930 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.02498 |
[BP] GO:0051931 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
3.02498 |
[BP] GO:0097746 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
3.00796 |
[BP] GO:0035296 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
3.00796 |
[BP] GO:0030335 |
positive regulation of cell migration
|
ALOX12, APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
3.00043 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9, DRD2, FABP3, PPARA, TRPV1 |
2.98971 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, ESR1, FLT3, HTR1A, MET, MIF, PIM1, SRC, TYR |
2.98251 |
[BP] GO:0070989 |
oxidative demethylation
|
CYP1A2, CYP2D6, CYP3A4 |
2.92375 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE3B, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.92298 |
[BP] GO:0051952 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
2.9162 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, FLT3, IGF1R, KDR, PIM1, SRC |
2.90634 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX12, ALOX15, ALOX5, MIF |
2.89662 |
[BP] GO:2000147 |
positive regulation of cell motility
|
ALOX12, APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.8844 |
[BP] GO:0050880 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
2.87687 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.87687 |
[BP] GO:0031635 |
None
|
OPRK1, OPRM1 |
2.87687 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.87687 |
[BP] GO:2001301 |
lipoxin biosynthetic process
|
ALOX12, ALOX15 |
2.87687 |
[BP] GO:2001302 |
lipoxin A4 metabolic process
|
ALOX12, ALOX15 |
2.87687 |
[BP] GO:2001303 |
lipoxin A4 biosynthetic process
|
ALOX12, ALOX15 |
2.87687 |
[BP] GO:0035150 |
None
|
ADORA1, DRD1, HMGCR, HTR1A, HTR2A, HTR7 |
2.87362 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, ALOX12, CYP19A1, DRD1, DRD2, HMGCR, MIF, PPARA |
2.86678 |
[BP] GO:0070848 |
response to growth factor
|
APP, KDR, NR3C1, OPRD1, OPRM1, PDE3A, SRC, TRPV1 |
2.86678 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.84959 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CYP19A1, DRD2, HMGCR, HTR1A, HTR2A, MIF, MMP12, OPRK1, OPRM1, SRC |
2.84704 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FABP3, HTR2A, IGF1R, MET, MMP12, NR3C1, PPARA, RORC, SRC, TNKS, TNKS2, TRPV1 |
2.82 |
[BP] GO:0006352 |
DNA-templated transcription, initiation
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
2.82 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.82 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
ALOX12, APP, BCL2, DRD1, F3, IGF1R, KDR, MET, MMP9, SRC |
2.81769 |
[BP] GO:0032868 |
None
|
FABP3, HSD11B2, OPRK1, PDE3B, PPARA, SRC |
2.78402 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, HSD11B2, HTR1A, MIF, MMP2, MMP9, OPRD1, OPRK1, OPRM1, PPARA, PTPN1, SRC, TRPV1 |
2.76494 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.76494 |
[BP] GO:0006198 |
None
|
PDE10A, PDE3A, PDE3B |
2.76494 |
[BP] GO:0051967 |
None
|
ADORA1, DRD2, HTR2A |
2.76494 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, MIF, MMP12, OPRK1, SRC, TRPV1 |
2.75256 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
2.73558 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, MMP9, OPRM1, PTPN1, SRC, TNKS, XDH |
2.72221 |
[BP] GO:0006195 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.69107 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, SRC |
2.69107 |
[BP] GO:0050965 |
None
|
ADORA1, HTR2A, TRPV1 |
2.6814 |
[BP] GO:0050961 |
None
|
ADORA1, HTR2A, TRPV1 |
2.6814 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, MIF, MMP12, OPRK1, SRC, TRPV1 |
2.67112 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR2A |
2.67016 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD1, DRD2, HTR2A |
2.67016 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, FLT3, HSD11B2, NR3C1, SRC |
2.66714 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX12, ALOX15, ALOX5, CBR1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, FABP3, GBA2, MIF, PIM1, PPARA, TYR |
2.66714 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APP, AURKB, BCL2, CDC25B, CDK6, CSNK2A1, CYP1A1, DRD2, MIF, PDE3A, SENP6, TNKS |
2.66126 |
[BP] GO:2001023 |
None
|
DRD1, DRD2, HTR2A, MET, OPRK1 |
2.66013 |
[BP] GO:0044248 |
cellular catabolic process
|
ACHE, AKR1B10, AOX1, AURKB, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, FABP3, FABP4, GBA2, PDE10A, PDE3A, PDE3B, SRC, XDH |
2.63299 |
[BP] GO:0042391 |
None
|
ADORA1, APP, BCL2, DRD1, KDR, OPRD1, OPRM1, SRC, TRPV1 |
2.62125 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.61003 |
[BP] GO:0019372 |
lipoxygenase pathway
|
ALOX12, ALOX15, ALOX5 |
2.61003 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, DRD1, DRD2, TNKS, TNKS2 |
2.59217 |
[BP] GO:0031667 |
response to nutrient levels
|
ALPL, BCL2, CYP1A1, HMGCR, HSD11B2, OPRM1, SRC, TRPV1, TYR |
2.58496 |
[BP] GO:0051094 |
positive regulation of developmental process
|
ALOX12, APP, AXL, BCL2, CA2, CYP1B1, DRD2, ESRRB, F3, HMGCR, HTR2A, KDR, OPRM1, PDE3A, PIM1, SRC |
2.57032 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, FLT3, HSD11B2, NR3C1, SRC |
2.56339 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.54433 |
[BP] GO:0050730 |
None
|
ADORA1, APP, FLT3, HTR2A, MIF, PTPN1, SRC |
2.54108 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, MIF, MMP9, PTPN1, SRC |
2.54108 |
[BP] GO:1904355 |
positive regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.54108 |
[BP] GO:0009214 |
None
|
PDE10A, PDE3A, PDE3B |
2.54108 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
APP, AURKB, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, HTR2A, IGF1R, MET, MMP12, NR3C1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2 |
2.53889 |
[BP] GO:0008542 |
None
|
APP, DRD1, DRD2, HMGCR |
2.53889 |
[BP] GO:0003014 |
None
|
ADORA1, AKR1B1, BCL2, DRD2, HSD11B2 |
2.52561 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APP, AURKB, BCL2, CA9, CDC25B, CDK6, CSNK2A1, CYP1A2, CYP1B1, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MET, MIF, MMP12, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.51574 |
[BP] GO:0043266 |
None
|
ADORA1, DRD1, DRD2, HTR2A, OPRK1 |
2.48983 |
[BP] GO:0009822 |
alkaloid catabolic process
|
CYP2D6, CYP3A4 |
2.48983 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.48983 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.48983 |
[BP] GO:0016137 |
None
|
AKR1B1, AKR1B10, GBA2 |
2.4795 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, XDH |
2.4781 |
[BP] GO:0009314 |
response to radiation
|
APP, AURKB, BCL2, DRD1, DRD2, HMGCR, OPRK1, OPRM1, TYR |
2.47776 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, APP, AURKB, BCL2, CDC25B, DRD2, ESR1, ESR2, F3, FLT3, HTR2A, MET, MIF, MMP9, OPRD1, PTPN1, SRC, TNKS, XDH |
2.47776 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, PTPN1, SRC, TNKS |
2.47422 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CDK6, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, PIM1, SRC, TNKS |
2.47122 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
ALOX12, BCL2, CYP1A1, CYP1A2, CYP1B1 |
2.42086 |
[BP] GO:0016048 |
None
|
ADORA1, HTR2A, TRPV1 |
2.41929 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.41929 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, KDR, NR3C1, OPRD1, PDE3A, SRC, TRPV1 |
2.41358 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DRD2, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC, TNKS, TNKS2 |
2.39991 |
[BP] GO:0007632 |
None
|
APP, DRD1, DRD2, HMGCR |
2.39991 |
[BP] GO:0032210 |
regulation of telomere maintenance via telomerase
|
AURKB, SRC, TNKS, TNKS2 |
2.39991 |
[BP] GO:0044283 |
None
|
AKR1B1, ALOX12, ALOX15, ALOX5, CYP19A1, CYP1A1, CYP3A4, HMGCR, MIF |
2.36307 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, FLT3, HMGCR, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.36253 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
MMP1, MMP12, MMP2, MMP9, TRPV1 |
2.35528 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, HTR2A, MIF, PTPN1, SRC |
2.34556 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, AXL, BCL2, CYP1B1, MMP9, SRC |
2.33297 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.33171 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, DRD1, DRD2, ESR1, FABP3, HTR2A, TRPV1 |
2.32541 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, AXL, BCL2, CYP1B1, SRC |
2.32541 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, AXL, CYP1B1, MMP9, SRC |
2.32541 |
[BP] GO:0032094 |
None
|
CYP1A1, HSD11B2, OPRM1 |
2.30948 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
2.30948 |
[BP] GO:0007626 |
None
|
APP, DRD1, DRD2, OPRD1, OPRK1, OPRM1 |
2.27985 |
[BP] GO:1901361 |
None
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP3A4, PDE10A, PDE3A, PDE3B, XDH |
2.27276 |
[BP] GO:0042698 |
ovulation cycle
|
AXL, OPRK1, OPRM1 |
2.25555 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.25555 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CYP19A1, DRD2, HMGCR, HTR1A, HTR2A, OPRK1 |
2.25415 |
[BP] GO:0071396 |
cellular response to lipid
|
AXL, CDK6, ESR1, FLT3, NR3C1, OPRK1, RORC, SRC |
2.25343 |
[BP] GO:0034502 |
protein localization to chromosome
|
AURKB, ESR1, TNKS, TNKS2 |
2.25343 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, DRD1, DRD2, HTR2A |
2.25343 |
[BP] GO:0070988 |
demethylation
|
CYP1A1, CYP1A2, CYP2D6, CYP3A4 |
2.25343 |
[BP] GO:0007198 |
None
|
HTR1A, HTR7 |
2.25343 |
[BP] GO:0070213 |
None
|
TNKS, TNKS2 |
2.25343 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.25343 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.25343 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.2499 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, DRD2, F3, FLT3, IGF1R, KDR, MET, MIF, MMP2, MMP9, PTPN1, SRC, TNKS, TNKS2, TRPV1 |
2.2499 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, MMP2, MMP9 |
2.24743 |
[BP] GO:1904356 |
regulation of telomere maintenance via telomere lengthening
|
AURKB, SRC, TNKS, TNKS2 |
2.23729 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.21833 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.21757 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DRD1, DRD2, ESR1, F3, FABP4, FLT3, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP9, OPRD1, OPRK1, OPRM1, PTPN1, SRC, XDH |
2.20679 |
[BP] GO:0051172 |
None
|
APP, AURKB, CSNK2A1, DRD2, ESR1, ESR2, ESRRA, FABP4, HMGCR, IGF1R, MIF, MMP12, MMP9, NR3C1, OPRM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, XDH |
2.20303 |
[BP] GO:0050890 |
None
|
ADORA1, APP, DRD1, DRD2, HMGCR, HTR2A, OPRK1 |
2.18881 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.18398 |
[BP] GO:0007210 |
None
|
HTR1A, HTR2A, HTR7 |
2.17396 |
[BP] GO:0098664 |
None
|
HTR1A, HTR2A, HTR7 |
2.17396 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.17396 |
[BP] GO:0009166 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.17008 |
[BP] GO:0046888 |
None
|
ADORA1, DRD2, HMGCR, OPRK1 |
2.17008 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, AXL, CYP1B1, KDR, OPRD1 |
2.16138 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.15203 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CDK6, CYP1A1, CYP1A2, HMGCR, HSD11B2, HTR2A, MMP12, OPRK1, OPRM1, SRC, TRPV1, TYR |
2.14994 |
[BP] GO:0050795 |
None
|
ADORA1, DRD2, HTR1A, HTR2A |
2.14994 |
[BP] GO:0051881 |
regulation of mitochondrial membrane potential
|
BCL2, KDR, OPRD1, SRC |
2.14994 |
[BP] GO:2000573 |
positive regulation of DNA biosynthetic process
|
AURKB, SRC, TNKS, TNKS2 |
2.14994 |
[BP] GO:0043434 |
None
|
FABP3, HSD11B2, OPRK1, PDE3B, PPARA, SRC, TRPV1 |
2.1478 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DRD2, ESR1, ESR2, IGF1R, KDR, MET, MMP1, MMP9, OPRD1, PDE3A, PTPN1, SENP6, SRC, TNKS, TNKS2 |
2.13287 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.13287 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.13015 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, HTR2A, PPARA, SRC |
2.12394 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CDC25B, CYP19A1, ESR1, ESRRB, HSD17B2, PDE3A, SRC |
2.10938 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DRD2, FABP4, FLT3, HMGCR, HTR2A, IGF1R, MIF, PTPN1, SRC |
2.10584 |
[BP] GO:0009416 |
response to light stimulus
|
APP, AURKB, BCL2, DRD1, DRD2, HMGCR, TYR |
2.09185 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.09144 |
[BP] GO:1904353 |
regulation of telomere capping
|
AURKB, TNKS, TNKS2 |
2.09144 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
APP, BCL2, DRD2, TNKS2 |
2.08844 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.08708 |
[BP] GO:0043696 |
None
|
CDK6, ESRRB |
2.08708 |
[BP] GO:0043697 |
None
|
CDK6, ESRRB |
2.08708 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.08708 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.08708 |
[BP] GO:0051122 |
hepoxilin biosynthetic process
|
ALOX12, ALOX15 |
2.08708 |
[BP] GO:0051121 |
hepoxilin metabolic process
|
ALOX12, ALOX15 |
2.08708 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.08708 |
[BP] GO:0045913 |
None
|
ESRRB, HTR2A, PPARA, SRC |
2.0748 |
[BP] GO:0051051 |
negative regulation of transport
|
ADORA1, APP, BCL2, DRD2, HMGCR, HTR2A, MMP9, OPRK1, OPRM1 |
2.05954 |
[BP] GO:1904357 |
None
|
SRC, TNKS, TNKS2 |
2.05701 |
[BP] GO:0042180 |
None
|
AKR1B1, AKR1B10, CYP19A1, HMGCR |
2.05525 |
[BP] GO:1901292 |
None
|
PDE10A, PDE3A, PDE3B, XDH |
2.05525 |
[BP] GO:0007268 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.04972 |
[BP] GO:0098916 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.04972 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PTPN1, SRC |
2.04705 |
[BP] GO:0007154 |
None
|
ADORA1, AXL, BCL2, DRD1, DRD2, ESR2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1, TRPV1 |
2.03776 |
[BP] GO:0007416 |
None
|
ACHE, APP, DRD1, DRD2 |
2.03776 |
[BP] GO:0031644 |
None
|
ADORA1, OPRD1, OPRK1, OPRM1 |
2.03776 |
[BP] GO:0050789 |
regulation of biological process
|
ACHE, ADORA1, ADORA3, AKR1B1, ALOX12, ALOX15, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRK1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, XDH |
2.03776 |
[BP] GO:1901360 |
None
|
ACHE, AKR1B1, AKR1B10, ALOX12, AOX1, APP, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR1A, NR3C1, PDE10A, PDE3A, PDE3B, PPARA, RORC, TYR, XDH |
2.02982 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, BCL2, CYP19A1, CYP1B1, DRD2, MIF |
2.02593 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CYP1A1, CYP1A2, OPRK1, OPRM1, SRC |
2.02593 |
[BP] GO:0042755 |
None
|
OPRD1, OPRK1, OPRM1 |
2.02593 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.02593 |
[BP] GO:0014059 |
None
|
DRD2, HTR2A, OPRK1 |
2.02593 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, FLT3, IGF1R, KDR, MET, SENP6, SRC, TNKS |
2.00826 |
[BP] GO:0099536 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.00248 |
[BP] GO:0099537 |
None
|
DRD1, DRD2, HTR2A, HTR7, OPRD1, OPRK1, OPRM1 |
2.00248 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
FABP3, FLT3, HTR2A, SRC |
2.0024 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, CA4, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, TRPV1 |
3.86857 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PDE10A, PDE3B, PIM1, PTPN1, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, TYR |
3.83534 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA7, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, HTR2A, KDR, MIF, MMP2, MMP9, NR3C1, OPRM1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SIGMAR1, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
3.65878 |
[CC] GO:0005783 |
None
|
ADORA1, APP, BCL2, CA4, CYP19A1, CYP2D6, FLT3, GBA2, HMGCR, KDR, OPRM1, PDE3B, PTPN1, SIGMAR1, XDH |
3.3072 |
[CC] GO:0031253 |
None
|
ADORA1, CA4, CA9, DRD1, DRD2, OPRD1, OPRM1, SRC, TRPV1 |
3.29206 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, APP, AXL, DRD1, DRD2, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, TRPV1 |
3.04268 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, PDE3A, PDE3B, PTPN1, SIGMAR1, SRC, TRPV1, TYR |
2.9814 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, FLT3, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, PTPN1, SIGMAR1 |
2.95742 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B2, SIGMAR1 |
2.86678 |
[CC] GO:0032589 |
None
|
ADORA1, OPRD1, OPRM1, TRPV1 |
2.76494 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ALOX12, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CSNK2A1, DRD1, DRD2, ESR1, F3, FLT3, GBA2, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP2, OPRD1, OPRK1, OPRM1, PIM1, PTPN1, SRC, TRPV1 |
2.41984 |
[CC] GO:0044463 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC, TRPV1 |
2.31953 |
[CC] GO:0120038 |
None
|
ADORA1, AKR1B1, APP, CA4, CA9, DRD1, DRD2, HTR2A, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC, TRPV1 |
2.31953 |
[CC] GO:0043227 |
membrane-bounded organelle
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALPL, AOX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA4, CBR1, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, FUT7, GBA2, HMGCR, HTR2A, IGF1R, KDR, MIF, MMP12, MMP2, MMP9, NR3C1, OPRD1, OPRM1, PDE3B, PIM1, PPARA, PTPN1, RORC, SIGMAR1, SRC, TNKS, TNKS2, TYR, XDH |
2.25343 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ALOX15, APP, AXL, CA2, CA4, CA9, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, SRC, TRPV1 |
2.24421 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, DRD1, DRD2, HTR2A, MET, OPRD1, OPRM1, SIGMAR1, SRC, TRPV1 |
2.1231 |
[CC] GO:0005829 |
cytosol
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, APP, AURKB, BCL2, CA1, CA2, CA7, CBR1, CDC25B, CDK6, CSNK2A1, FABP3, FABP4, FLT3, HSD17B1, HTR2A, MIF, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
2.03704 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, APP, CA1, CA12, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PIM1, PPARA, PTPN1, RORC, TNKS, TYR, XDH |
16.3299 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, FLT3, HMGCR, HSD17B1, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, SRC, TNKS, TNKS2, TRPV1, TYR, XDH |
11.889 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
9.79082 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, ALPL, AOX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CBR1, CDC25B, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, F3, FLT3, FUT7, GBA2, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MIF, MMP1, MMP12, MMP2, MMP9, PDE10A, PDE3A, PDE3B, PIM1, PTPN1, SENP6, SRC, TNKS, TNKS2, TYR, XDH |
9.79082 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, HTR1A, HTR2A, HTR7, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TRPV1, TYR, XDH |
9.44588 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX12, ALOX15, ALOX5, AOX1, CBR1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, TYR, XDH |
8.20475 |
[MF] GO:0005506 |
iron ion binding
|
ALOX12, ALOX15, ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, XDH |
7.53406 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD11B2, HSD17B1, NR3C1, RORC |
7.37747 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, RORC, SIGMAR1, TRPV1 |
7.32704 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, AOX1, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2, XDH |
6.98769 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, AXL, CDK6, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, RORC, SIGMAR1, TRPV1 |
6.79633 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.79249 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PPARA, PTPN1, RORC, TNKS |
6.77371 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
6.52402 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, RORC, SIGMAR1, TRPV1 |
6.44511 |
[MF] GO:0046872 |
metal ion binding
|
ALOX12, ALOX15, ALOX5, ALPL, AOX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, MMP1, MMP12, MMP2, MMP9, NR3C1, PDE10A, PDE3A, PDE3B, PIM1, PPARA, PTPN1, RORC, TNKS, TNKS2, TRPV1, TYR, XDH |
6.35664 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
6.1558 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, NR3C1, PPARA, RORC |
5.95928 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, NR3C1, OPRD1, OPRK1, OPRM1, PPARA, RORC, SIGMAR1, TRPV1 |
5.7241 |
[MF] GO:0008289 |
lipid binding
|
ALOX15, AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F3, FABP3, FABP4, HSD11B2, HSD17B1, NR3C1, PPARA, RORC, TRPV1 |
5.59627 |
[MF] GO:0004985 |
None
|
OPRD1, OPRK1, OPRM1, SIGMAR1 |
5.41362 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
5.3273 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4 |
5.27053 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, CBR1, HMGCR, HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
5.25553 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, FLT3, HTR2A, IGF1R, KDR, MET, PDE10A, PIM1, PPARA, SIGMAR1, SRC, TRPV1 |
5.10791 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.08878 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, RORC |
5.08878 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, TYR |
4.72899 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, HTR1A, HTR2A, HTR7 |
4.16536 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, HMGCR, HSD11B2, HSD17B1, SRC, XDH |
4.15295 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
3.9392 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, SRC |
3.7676 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, TRPV1 |
3.65878 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, AXL, DRD1, DRD2, F3, FLT3, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, OPRD1, OPRK1, OPRM1, SIGMAR1, TRPV1 |
3.65878 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, TYR |
3.47649 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.36512 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
3.28108 |
[MF] GO:0030594 |
None
|
DRD1, DRD2, HTR1A, HTR2A, HTR7, OPRM1 |
3.27516 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.27406 |
[MF] GO:0016229 |
steroid dehydrogenase activity
|
HSD11B1, HSD11B2, HSD17B1, HSD17B2 |
3.26117 |
[MF] GO:0016829 |
lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA7, CA9 |
3.04868 |
[MF] GO:0043176 |
None
|
HTR1A, HTR2A, HTR7 |
3.02772 |
[MF] GO:0051378 |
None
|
HTR1A, HTR2A, HTR7 |
3.02772 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2D6, CYP3A4 |
3.02498 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.87687 |
[MF] GO:0047977 |
hepoxilin-epoxide hydrolase activity
|
ALOX12, ALOX15 |
2.87687 |
[MF] GO:0003845 |
None
|
HSD11B1, HSD11B2 |
2.87687 |
[MF] GO:0004119 |
None
|
PDE3A, PDE3B |
2.87687 |
[MF] GO:0099528 |
None
|
HTR1A, HTR2A, HTR7, OPRM1 |
2.87312 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, FLT3, IGF1R, KDR, MET |
2.86678 |
[MF] GO:0047555 |
None
|
PDE10A, PDE3A, PDE3B |
2.76494 |
[MF] GO:0004115 |
None
|
PDE10A, PDE3A, PDE3B |
2.6814 |
[MF] GO:0016903 |
None
|
AKR1B1, AKR1B10, AOX1, XDH |
2.66437 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, CSNK2A1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SRC |
2.57455 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.48983 |
[MF] GO:0004052 |
arachidonate 12-lipoxygenase activity
|
ALOX12, ALOX15 |
2.48983 |
[MF] GO:0051120 |
hepoxilin A3 synthase activity
|
ALOX12, ALOX15 |
2.48983 |
[MF] GO:0042165 |
neurotransmitter binding
|
ACHE, HTR1A, HTR2A, HTR7 |
2.42229 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, APP, BCL2, CSNK2A1, DRD2, ESR1, ESR2, FLT3, HMGCR, IGF1R, KDR, MET, MIF, MMP9, TRPV1, TYR, XDH |
2.36352 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.32541 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, ESRRB, FLT3, HTR2A, IGF1R, KDR, MMP12, MMP9, PPARA, PTPN1, SRC |
2.31953 |
[MF] GO:0008227 |
None
|
DRD2, HTR1A, HTR2A, HTR7 |
2.29647 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, FLT3, IGF1R, KDR, MET, SRC |
2.25568 |
[MF] GO:0042923 |
None
|
OPRD1, OPRK1, OPRM1 |
2.25555 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.25343 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.25343 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.25343 |
[MF] GO:0004993 |
None
|
HTR1A, HTR2A, HTR7 |
2.17396 |
[MF] GO:0004114 |
None
|
PDE10A, PDE3A, PDE3B |
2.17396 |
[MF] GO:0099589 |
None
|
HTR1A, HTR2A, HTR7 |
2.17396 |
[MF] GO:0097159 |
organic cyclic compound binding
|
ADORA1, AOX1, APP, AURKB, AXL, BCL2, CDK6, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, CYP3A4, DRD1, DRD2, ESR1, ESR2, ESRRA, ESRRB, FLT3, HMGCR, HSD11B2, HSD17B1, HTR1A, HTR2A, HTR7, IGF1R, KDR, MET, MMP12, NR3C1, PDE10A, PDE3A, PIM1, PPARA, PTPN1, RORC, SRC, TRPV1, XDH |
2.13287 |
[MF] GO:0004112 |
None
|
PDE10A, PDE3A, PDE3B |
2.13287 |
[MF] GO:0016702 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen
|
ALOX12, ALOX15, ALOX5 |
2.09144 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.08708 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.08708 |
[MF] GO:0016701 |
oxidoreductase activity, acting on single donors with incorporation of molecular oxygen
|
ALOX12, ALOX15, ALOX5 |
2.05701 |
[MF] GO:0051721 |
None
|
BCL2, HMGCR, PTPN1 |
2.02593 |